-

LIVE NATION UPDATE: Rosen Law Firm Provides Live Nation Entertainment, Inc. Investors Update in Securities Class Action – LYV

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, provides this update to purchasers of Live Nation Entertainment, Inc. (NYSE: LYV) securities in regard to the pending securities class action seeking recovery of investor losses. The suit alleges that Live Nation and certain of its officers and directors issued materially false and misleading statements to investors arising from Live Nation’s improper anticompetitive conduct.

On October 18, 2023, the United States District Court for the Central District of California appointed The Rosen Law Firm as Co-Lead Counsel in this securities class action. On February 23, 2024, the Court denied the defendants’ motion to dismiss. The case is currently in the discovery phase.

If you require additional information or want to join the Live Nation class action, go to https://rosenlegal.com/submit-form/?case_id=18184 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed.

If you purchased Live Nation securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

The Rosen Law Firm, P.A.

NYSE:LYV

Release Versions

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

More News From The Rosen Law Firm, P.A.

SKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025. Skye is a clinical stage biopharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Skye Bioscience, Inc. (NASDAQ: SKYE) Misled Investors Regarding its Business Ope...

SFM Deadline: Rosen Law Firm Urges Sprouts Farmers Market, Inc. (NASDAQ: SFM) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors a class action on behalf of purchasers of securities and sellers of put options of Sprouts Farmers Market, Inc. (NASDAQ: SFM) between June 4, 2025 and October 29, 2025. Sprouts describes itself as a “specialty grocery store chain that operates throughout the US, with more than 450 stores across 24 states.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3...

Rosen Law Firm Urges Ardent Health, Inc. (NYSE: ARDT) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025. Ardent Health describes itself as a company that “operates acute care hospitals and other healthcare facilities.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Al...
Back to Newsroom